| Literature DB >> 30838136 |
Dhatri Kotekal1, Melanie Worley1, Hemal Patel2, Laura Jensen1, Godwin Y Dogbey3, David Drozek4.
Abstract
Intensive therapeutic lifestyle modification programs, such as the Complete Health Improvement Program (CHIP), reduce cardiovascular disease (CVD) risk factors. However, there are little data on how participation in CHIP with a household member can affect CVD biomarkers. This study focuses on the benefit of joint participation of household members in CHIP in order to have a better outcome in improving CVD risk factors compared with lone or individual participation. Data from 20 CHIP classes offered from 2011 to 2015 in Athens, Ohio, where each class was conducted over 2-4 months, consisting of 16-18 sessions, were collected. Body mass index (BMI), blood pressure, fasting glucose, and lipid profiles were measured before and near the completion of each class. A statistically significant greater reduction in BMI (p = 0.003) in those who attended with a household member compared to those who attended as individuals was found. CHIP has some effect on various CVD risk factors for those who attend intensive therapeutic lifestyle modification programs with an accompanying household member. Hence, encouragement of participation with a family member or a "buddy" may be prudent, especially if weight reduction is a key program participation goal. Further evaluation of the "buddy effect" involving both of those residing in the same household and those who do not but nevertheless provide mutual support is warranted.Entities:
Year: 2019 PMID: 30838136 PMCID: PMC6374866 DOI: 10.1155/2019/9648926
Source DB: PubMed Journal: Adv Prev Med
Demographic characteristics of the CHIP study participants.
|
| |
|
| |
| Participation Group, |
|
| Individual | 340 (66.4) |
| Household | 172 (33.6) |
| Gender, |
|
| Male | 134 (26.2) |
| Female | 378 (73.8) |
Biomarker outcomes for CHIP participation alone (Individual) or with an accompanying household member (Household). Abbreviations. Standard deviation (SD), total cholesterol (TC), high density lipoprotein (HDL), triglycerides (TG), fasting blood glucose (GLU), body mass index (BMI), systolic blood pressure (BPSYS), and diastolic blood pressure (BPDIA).
|
|
|
|
| ||||
|
|
|
|
|
|
| ||
|
| |||||||
| TC | 340 | -18.6 (9.8) | 25.4 | 172 | -21.9 (12.0) | 27.4 | .177 |
| HDL | 340 | -4.3 (8.5) | 6.8 | 172 | -4.02 (8.7) | 7.4 | .717 |
| LDL | 339 | -14.5 (11.4) | 21.5 | 169 | -16.56 (14.8) | 23.2 | .320 |
| TG | 340 | -3.9 (3.7) | 48.1 | 172 | -9.84 (7.5) | 51.5 | .198 |
| GLU | 337 | -6.32 (5.9) | 24.1 | 172 | -4.9 (4.7) | 11.1 | .468 |
| BMI∗ | 328 | -1.02 (3.2) | 1.1 | 168 | -1.29 (4.1) | 0.8 | .003 |
| BPSYS | 322 | -5.71 (4.4) | 14.6 | 168 | -7.34 (5.7) | 14.1 | .238 |
| BPDIA | 322 | -1.76 (2.3) | 9.7 | 168 | -2.8 (3.6) | 10.1 | .267 |
| PULSE | 296 | -4.47 (5.9) | 13.2 | 158 | -2.5 (3.5) | 10.1 | .107 |
Note. ∗Statistically significant at .01 level.
|
|
|
|
|
|
| |||
| TC mg/dL | 340 | 189.2 | 170.7 |
| HDL mg/dL | 340 | 50.2 | 46.0 |
| LDL mg/dL | 336 | 114.6 | 100.3 |
| TG mg/dL | 341 | 127.1 | 123.2 |
| GLU mg/dL | 337 | 105.5 | 99.2 |
| BMI kg/m2 | 321 | 32.3 | 31.3 |
| BPSYS mmHg | 320 | 129.6 | 123.8 |
| BPDIA mmHg | 322 | 77.8 | 76.1 |
| PULSE beats per minute | 296 | 75.7 | 71.0 |
|
|
|
|
|
|
| |||
| TC mg/dL | 172 | 182.9 | 161.0 |
| HDL mg/dL | 172 | 46.2 | 42.2 |
| LDL mg/dL | 169 | 111.0 | 94.9 |
| TG mg/dL | 172 | 131.1 | 121.3 |
| GLU mg/dL | 172 | 104.3 | 99.4 |
| BMI kg/m2 | 168 | 31.6 | 30.2 |
| BPSYS mmHg | 168 | 129.3 | 122.0 |
| BPDIA mmHg | 168 | 77.8 | 75.0 |
| PULSE beats per minute | 158 | 72.9 | 70.4 |